{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:04:22Z","timestamp":1778043862961,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.cancergen.2012.12.001","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T22:45:19Z","timestamp":1357771519000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with\u00a0potential impact for clinical management"],"prefix":"10.1016","volume":"206","author":[{"given":"Alexander","family":"Valent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Penault-Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Cayre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.12.001_bib1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/cdd.2010.145","article-title":"Illicit survival of cancer cells during polyploidization and depolyploidization","volume":"18","author":"Vitale","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cancergen.2012.12.001_bib2","doi-asserted-by":"crossref","first-page":"e26946","DOI":"10.1371\/journal.pone.0026946","article-title":"Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30,698 patients","volume":"6","author":"Ying-Yi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2012.12.001_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12094-011-0686-x","article-title":"Efficacy of taxanes as\u00a0adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials","volume":"13","author":"Gines","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.12.001_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/dji112","article-title":"Epidermal growth factor receptor gene and protein and gefinitib sensitivity in non-small-cell lung cancer","volume":"97","author":"Cappuzzo","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.12.001_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/jcp.2009.066548","article-title":"EGFR fluorescence in situ hybridization assay: guidelines for application to non-small-cell lung cancer","volume":"62","author":"Varella-Garcia","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jclinpath-2011-200353","article-title":"Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory ring study","volume":"65","author":"Sartore-Bianchi","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JTO.0b013e3181fb7cd6","article-title":"Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer","volume":"6","author":"Salido","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-012-1281-4","article-title":"EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations","volume":"461","author":"Thunnissen","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cancergen.2012.12.001_bib11","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2010.29.6673","article-title":"Human epidermal growth factor receptor 2 testing in 2010: does chromosome 17 centromere copy number make any difference?","volume":"28","author":"Ross","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.cancergen.2012.12.001_bib12","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0960-9776(11)70300-9","article-title":"Pathological work up of the primary tumor: getting the proper information out of it","volume":"20","author":"Viale","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.cancergen.2012.12.001_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.patbio.2008.03.009","article-title":"Diagnosis of HER2 gene amplification in breast carcinoma","volume":"56","author":"Couturier","year":"2008","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.cancergen.2012.12.001_bib14","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1200\/JCO.2007.13.4296","article-title":"Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing","volume":"26","author":"Vanden Bempt","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.humpath.2010.04.023","article-title":"Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer","volume":"42","author":"Zhu","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12253-012-9518-8","article-title":"Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer","volume":"18","author":"Zaczek","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cancergen.2012.12.001_bib17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/modpathol.2009.61","article-title":"Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma","volume":"22","author":"Krishnamurti","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1158\/1078-0432.CCR-09-1643","article-title":"Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancer","volume":"16","author":"Downey","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.12.001_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1470-2045(09)70063-4","article-title":"Breast cancer and aneusomy 17: implication for carcinogenesis and therapeutic response","volume":"10","author":"Reinholz","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.2574","article-title":"Does chromosome 17 copy number predict polysomy in breast cancer? A\u00a0fluorescence in situ hybridization and microarray-based CGH analysis","volume":"219","author":"Marchi\u00f2","year":"2009","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/1471-2407-10-396","article-title":"Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity","volume":"10","author":"Gunn","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2012.12.001_bib22","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1200\/JCO.2011.36.0107","article-title":"Determining true HER2 status in breast cancer with polysomy by using alternative chromosome 17 reference genes: implications for\u00a0anti-HER2 targeted therapy","volume":"29","author":"Tse","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-009-0539-2","article-title":"Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification","volume":"120","author":"Moelans","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2012.12.001_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cncr.25580","article-title":"Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17","volume":"117","author":"Vranic","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.12.001_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.pas.0000165528.78945.95","article-title":"The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study","volume":"29","author":"Downs-Kelly","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jcp.2007.050336","article-title":"The effect of chromosome 17 polysomy on HER2\/neu status in breast cancer","volume":"61","author":"Hyun","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib27","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/annonc\/mdp427","article-title":"Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastasis","volume":"21","author":"Aitken","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergen.2012.12.001_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1634\/theoncologist.2010-0059","article-title":"Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis","volume":"15","author":"Puzstai","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.cancergen.2012.12.001_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20020851","article-title":"Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification","volume":"196","author":"Difilippantonio","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cancergen.2012.12.001_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergencyto.2003.12.007","article-title":"Alternative pathways of\u00a0MYCN gene copy number increase in primary neuroblastoma tumors","volume":"153","author":"Valent","year":"2004","journal-title":"Cancer Genetics Cytogenetics"},{"key":"10.1016\/j.cancergen.2012.12.001_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrm3115","article-title":"Mitotic catastrophe: a mechanism for avoiding genomic instability","volume":"12","author":"Vitale","year":"2011","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:02Z","timestamp":1761896282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S2210776212002761"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.12.001","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with\u00a0potential impact for clinical management","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}